Dechra makes success of debut in PP market

debut_Adobe_230x150
By Silas Brown
20 Nov 2019

Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has sold euro and dollar US private placement notes, in a debut widely seen as a success.

Santander arranged the transaction, selling €50m of seven year notes and $100m of 10 year PPs according to market sources. This is a new sector for the market, so investors took a while to chew through the credit analysis.

Perhaps the closest company to Dechra to raise PPs ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.